# A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine

> **NCT05526820** · PHASE4 · COMPLETED · sponsor: **Sinovac (Dalian) Vaccine Technology Co., Ltd.** · enrollment: 450 (actual)

## Conditions studied

- Varicella

## Interventions

- **BIOLOGICAL:** The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

## Key facts

- **NCT ID:** NCT05526820
- **Lead sponsor:** Sinovac (Dalian) Vaccine Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-08
- **Primary completion:** 2021-04-08
- **Final completion:** 2022-02-27
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526820, "A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05526820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*